Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?
Akhtar
S
S
Pharmaceutical Sciences Institute, Aston University, Birmingham, UK. S.Akhtar@aston.ac.uk
Rossi
J J
JJ
D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D016376:Oligonucleotides, Antisense / Q000138:chemical synthesis / Q000627:therapeutic use*; D016337:RNA, Catalytic / Q000627:therapeutic use*; D012367:RNA, Viral / Q000187:drug effects
D016376:Oligonucleotides, Antisense; D016337:RNA, Catalytic; D012367:RNA, Viral